253 related articles for article (PubMed ID: 28292399)
21. Reducing the risk of obesity: defining the role of weight loss drugs.
Ling H; Lenz TL; Burns TL; Hilleman DE
Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541
[TBL] [Abstract][Full Text] [Related]
22. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
23. [Past, present and future of obesity pharmacotherapy].
Fábryová L
Vnitr Lek; 2010 Oct; 56(10):1058-64. PubMed ID: 21105452
[TBL] [Abstract][Full Text] [Related]
24. Medications for weight loss.
Mordes JP; Liu C; Xu S
Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):91-7. PubMed ID: 25692921
[TBL] [Abstract][Full Text] [Related]
25. Update on obesity pharmacotherapy.
Bray GA; Ryan DH
Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
[TBL] [Abstract][Full Text] [Related]
26. Obesity pharmacotherapy: what is next?
Colon-Gonzalez F; Kim GW; Lin JE; Valentino MA; Waldman SA
Mol Aspects Med; 2013 Feb; 34(1):71-83. PubMed ID: 23103610
[TBL] [Abstract][Full Text] [Related]
27. Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States.
Umashanker D; Shukla AP; Saunders KH; Aronne LJ
Curr Atheroscler Rep; 2017 Aug; 19(8):35. PubMed ID: 28660593
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.
Cornell S; D'Souza J
Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973
[TBL] [Abstract][Full Text] [Related]
29. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
[TBL] [Abstract][Full Text] [Related]
30. New medications for obesity management: changing the landscape of obesity treatment.
Boulghassoul-Pietrzykowska N; Franceschelli J; Still C
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):407-11. PubMed ID: 23974768
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro S
Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
[No Abstract] [Full Text] [Related]
32. Weight management in obesity - past and present.
Haslam D
Int J Clin Pract; 2016 Mar; 70(3):206-17. PubMed ID: 26811245
[TBL] [Abstract][Full Text] [Related]
33. Current pharmacotherapeutic concepts for the treatment of obesity in adults.
Idelevich E; Kirch W; Schindler C
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):75-90. PubMed ID: 19144669
[TBL] [Abstract][Full Text] [Related]
34. Do we need anti-obesity drugs?
Hainer V; Hainerová IA
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
[TBL] [Abstract][Full Text] [Related]
35. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs.
Drolet B; Simard C; Poirier P
Am J Cardiovasc Drugs; 2007; 7(4):273-88. PubMed ID: 17696568
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological approaches to intervention.
Guy-Grand B
Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
[TBL] [Abstract][Full Text] [Related]
37. Medications for weight reduction.
Bray GA
Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
[TBL] [Abstract][Full Text] [Related]
38. Willingness to pay for obesity pharmacotherapy.
Doyle S; Lloyd A; Birt J; Curtis B; Ali S; Godbey K; Sierra-Johnson J; Halford JC
Obesity (Silver Spring); 2012 Oct; 20(10):2019-26. PubMed ID: 22301901
[TBL] [Abstract][Full Text] [Related]
39. Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.
Srivastava G; Apovian C
Curr Obes Rep; 2018 Jun; 7(2):147-161. PubMed ID: 29504049
[TBL] [Abstract][Full Text] [Related]
40. Addressing the unmet medical need for safe and effective weight loss therapies.
Arbeeny CM
Obes Res; 2004 Aug; 12(8):1191-6. PubMed ID: 15340099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
